SARS-CoV-2 Seroprevalence in Delhi, India, During September-October 2021: A Population-Based Seroepidemiological Study

Background A previous community-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey in Delhi in January 2021 reported a seroprevalence of 50.52%. We conducted a repeat serosurvey to obtain a recent estimate of the seroprevalence of IgG SARS-CoV-2 in the general population o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Pragya, Basu, Saurav, Mishra, Suruchi, Gupta, Ekta, Agarwal, Reshu, Kale, Pratibha, Mundeja, Nutan, Charan, BS, Singh, Gautam, Singh, Mongjam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Epidemiology/Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420192/
https://www.ncbi.nlm.nih.gov/pubmed/36051724
http://dx.doi.org/10.7759/cureus.27428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420192/
https://www.ncbi.nlm.nih.gov/pubmed/36051724
http://dx.doi.org/10.7759/cureus.27428

Ejemplares similares